Anyone living with the Human Immunodeficiency Virus (HIV) has an indication for annual influenza vaccination. (Vaccination schedule and vaccination recommendations 2019). Influenza is a viral infection that has a significant impact on the health care system. However, vaccination coverage in France is still insufficient with regard to the objectives set at 75% by the WHO and the European Commission. For the 2019-2020 seasonal influenza vaccination campaign, flu vaccination by volunteer pharmacists has become possible throughout the country. Studies that have estimated vaccination coverage among HIV-positive populations are rare and show very low rates.
Cross-sectional study via a self-questionnaire given to all HIV-infected patients coming for a scheduled consultation as part of their HIV follow-up in the spring of 2020. Non-opposition letter given to the patient. Collection of data a posteriori from the medical file recorded in the eNadis patient file.
Study Type
OBSERVATIONAL
Enrollment
124
CH Tourcoing
Tourcoing, France
questionnaire influenza vaccine coverage
The objective of this questionnaire is to estimate the influenza vaccine coverage among PVVIH followed at the Tourcoing Hospital Center.
Time frame: through study completion, an average of 1 year
modalities of influenza vaccination
To identify the modalities of influenza vaccination when it is carried out
Time frame: through study completion, an average of 1 year
the drivers and disincentives to influenza vaccination
Estimate from patient reports the drivers and disincentives to influenza vaccination in a specific risk population.
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.